|
|
Volumn 19, Issue 1, 2001, Pages 143-148
|
|
Clinical significance of plasma nucleosome levels in cancer patients.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
DRUG DERIVATIVE;
ESTROGEN RECEPTOR;
PACLITAXEL;
PROGESTERONE RECEPTOR;
TAXOID;
TUMOR MARKER;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD;
COMPARATIVE STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
LEUKOCYTE COUNT;
MALE;
MASTECTOMY;
METABOLISM;
MIDDLE AGED;
NEOPLASM;
NUCLEOSOME;
PATHOLOGY;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMANS;
LEUKOCYTE COUNT;
MALE;
MASTECTOMY;
MIDDLE AGED;
NEOPLASMS;
NUCLEOSOMES;
PACLITAXEL;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
TAXOIDS;
TUMOR MARKERS, BIOLOGICAL;
MLCS;
MLOWN;
|
|
EID: 0035405519
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.19.1.143 Document Type: Article |
|
Times cited : (46)
|
|
References (0)
|
